DrugPatentWatch Database Preview
Ani Pharms Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for ANI PHARMS INC, and what generic alternatives to ANI PHARMS INC drugs are available?
ANI PHARMS INC has two hundred and twenty-nine approved drugs.
There is one US patent protecting ANI PHARMS INC drugs.
There are fourteen patent family members on ANI PHARMS INC drugs in eleven countries and eighty-four supplementary protection certificates in twelve countries.
Summary for Ani Pharms Inc
International Patents: | 14 |
US Patents: | 1 |
Tradenames: | 134 |
Ingredients: | 130 |
NDAs: | 229 |
Drugs and US Patents for Ani Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ani Pharms Inc | ETODOLAC | etodolac | TABLET, EXTENDED RELEASE;ORAL | 075943-003 | Jul 26, 2002 | DISCN | No | No | Start Trial | Start Trial | |||||
Ani Pharms Inc | ERYTHROMYCIN STEARATE | erythromycin stearate | TABLET;ORAL | 061591-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
Ani Pharms Inc | PROPAFENONE HYDROCHLORIDE | propafenone hydrochloride | TABLET;ORAL | 076550-002 | Apr 23, 2004 | AB | RX | No | No | Start Trial | Start Trial | ||||
Ani Pharms Inc | NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 074054-003 | Dec 31, 1992 | DISCN | No | No | Start Trial | Start Trial | |||||
Ani Pharms Inc | OXACILLIN SODIUM | oxacillin sodium | CAPSULE;ORAL | 062222-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
Ani Pharms Inc | FELBAMATE | felbamate | TABLET;ORAL | 202284-002 | Nov 4, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
Ani Pharms Inc | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | SOLUTION;ORAL | 075110-001 | Jun 18, 1998 | DISCN | No | No | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ani Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ani Pharms Inc | BRETHINE | terbutaline sulfate | TABLET;ORAL | 017849-002 | Approved Prior to Jan 1, 1982 | 4,011,258 | Start Trial |
Ani Pharms Inc | INDERAL LA | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018553-003 | Apr 19, 1983 | 4,138,475 | Start Trial |
Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-001 | Jun 4, 1998 | 5,703,110 | Start Trial |
Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-004 | Jun 4, 1998 | 5,705,517*PED | Start Trial |
Ani Pharms Inc | ARIMIDEX | anastrozole | TABLET;ORAL | 020541-001 | Dec 27, 1995 | RE36617*PED | Start Trial |
Ani Pharms Inc | ATACAND | candesartan cilexetil | TABLET;ORAL | 020838-002 | Jun 4, 1998 | 5,703,110 | Start Trial |
Ani Pharms Inc | ATACAND HCT | candesartan cilexetil; hydrochlorothiazide | TABLET;ORAL | 021093-003 | May 16, 2008 | 5,534,534*PED | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ANI PHARMS INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 4 mg, 8 mg, 16 mg and 32 mg | ➤ Subscribe | 2006-12-22 |
➤ Subscribe | Tablets | 32 mg/25 mg | ➤ Subscribe | 2009-03-06 |
➤ Subscribe | Tablets | 16 mg/12.5 mg and 32 mg/12.5 mg | ➤ Subscribe | 2008-06-25 |
International Patents for Ani Pharms Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Mexico | PA04003234 | Start Trial |
Australia | 2002330211 | Start Trial |
Japan | 4369752 | Start Trial |
Germany | 60233668 | Start Trial |
Spain | 2333306 | Start Trial |
Norway | 335070 | Start Trial |
Austria | 442134 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ani Pharms Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0454511 | 99C0009 | Belgium | Start Trial | PRODUCT NAME: IRBESARTAN / HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/98/086/001 19981015 |
0302769 | 98C0036 | Belgium | Start Trial | PRODUCT NAME: CLOPIDOGREL HYDROGENE SULFATE; REGISTRATION NO/DATE IN FRANCE: EU/1/98 /069/001 DU 19980715; REGISTRATION NO/DATE AT EEC: DU EU/1-/98/069/001 |
1109558 | 09C0001 | France | Start Trial | PRODUCT NAME: RANOLAZINE; REGISTRATION NO/DATE: EU/1/08/462/001-006 20080714 |
0454511 | SPC/GB99/008 | United Kingdom | Start Trial | PRODUCT NAME: 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-((2'-(TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-IMIDAZOLIN-5-ONE)(GENERIC NAME IRBESARTAN) OPTIONALLY IN THE FORM OF ONE OF ITS SALTS AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/98/086/001 19981015; UK EU/1/98/086/002 19981015; UK EU/1/98/086/003 19981015; UK EU/1/98/086/004 19981015; UK EU/1/98/086/005 19981015; UK EU/1/98/086/006 19981015 |
0392059 | SPC/GB02/046 | United Kingdom | Start Trial | PRODUCT NAME: MEMANTINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS; REGISTERED: UK EU/1/02/219/001 20020515; UK EU/1/02/219/002 20020515; UK EU/1/02/219/003 20020515; UK EU/1/02/219/004 20020515; UK EU/1/02/219/005 20020515; UK EU/1/02/219/006 20020515 |
0473687 | 99C0008 | Belgium | Start Trial | PRODUCT NAME: FOSPHENYTOINUM DINATRICUM; REGISTRATION NO/DATE: 19 IS 102 F12 19980901; FIRST REGISTRATION: GB PL00019/1057 19980204 |
0502314 | C300095 | Netherlands | Start Trial | PRODCUT NAME: TELMISARTAN, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH VERDRAAGBAAR ZOUT, EN HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/02/213/001-010 20020419 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.